We are live on ! Find out more
DMPV

Delphi Management Partners VIII Portfolio holdings

AUM $138M
1-Year Est. Return 56.74%
This Fund
S&P 500
This Quarter Est. Return
+24.31%
1 Year Est. Return
+56.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$145M
AUM Growth
-$7.34M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNDM icon
1
Tandem Diabetes Care
TNDM
$1.17B
$88.3M 60.95%
1,000,000
SENS icon
2
Senseonics Holdings Inc
SENS
$267M
$26M 17.95%
492,315
KPTI icon
3
Karyopharm Therapeutics
KPTI
$216M
$23.8M 16.44%
150,867
CALA
4
DELISTED
Calithera Biosciences, Inc
CALA
$5.87M 4.06%
121,335
MREO
5
Mereo BioPharma
MREO
$49.5M
$865K 0.6%
256,734

Similar funds

Delphi Management Partners VIII's Q1 2021 Portfolio in Review

As of Q1 2021, Delphi Management Partners VIII held 5 positions worth $145M, down 4.8% from $152M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. Delphi Management Partners VIII opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 92% a quarter earlier.

  • Delphi Management Partners VIII's ten largest holdings make up 100% of its $145M portfolio in Q1 2021.
  • Delphi Management Partners VIII opened 0 new positions and closed 0 in Q1 2021.
  • Delphi Management Partners VIII's portfolio value fell 4.8% quarter-over-quarter to $145M.

Based on Delphi Management Partners VIII's 13F filing for Q1 2021, filed 17 May 2021.